
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14102209
[patent_doc_number] => 20190092780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/083089
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083089 | Tricyclic compounds useful to treat orthomyxovirus infections | Mar 6, 2017 | Issued |
Array
(
[id] => 11704533
[patent_doc_number] => 20170173032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck'
[patent_app_type] => utility
[patent_app_number] => 15/450727
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13872
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450727 | Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck | Mar 5, 2017 | Issued |
Array
(
[id] => 11948167
[patent_doc_number] => 20170252319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Flavonoid-Poly(ethylene glycol) Complex Comprising Flavonoid Compounds and Poly(ethylene glycol) and Preparation Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/449011
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3978
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449011 | Flavonoid-Poly(ethylene glycol) Complex Comprising Flavonoid Compounds and Poly(ethylene glycol) and Preparation Method Thereof | Mar 2, 2017 | Abandoned |
Array
(
[id] => 13901669
[patent_doc_number] => 20190040039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => PIPERIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/079713
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079713 | Piperidine derivative | Feb 26, 2017 | Issued |
Array
(
[id] => 15281747
[patent_doc_number] => 10513528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Synthetic processes and intermediates
[patent_app_type] => utility
[patent_app_number] => 16/079469
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4495
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079469 | Synthetic processes and intermediates | Feb 22, 2017 | Issued |
Array
(
[id] => 16476195
[patent_doc_number] => 10851123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Prodrugs of phenolic TRPV1 agonists
[patent_app_type] => utility
[patent_app_number] => 16/078585
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43501
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078585 | Prodrugs of phenolic TRPV1 agonists | Feb 21, 2017 | Issued |
Array
(
[id] => 11669930
[patent_doc_number] => 20170158650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 15/435826
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21228
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435826 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | Feb 16, 2017 | Issued |
Array
(
[id] => 11949447
[patent_doc_number] => 20170253598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/435735
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42793
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435735 | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors | Feb 16, 2017 | Issued |
Array
(
[id] => 16492283
[patent_doc_number] => 10858307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Compositions and methods for treating liver cancer
[patent_app_type] => utility
[patent_app_number] => 15/999358
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4605
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999358
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999358 | Compositions and methods for treating liver cancer | Feb 15, 2017 | Issued |
Array
(
[id] => 12000174
[patent_doc_number] => 20170304327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'CANNABINOID RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/427303
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 67724
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427303
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427303 | Cannabinoid receptor modulators | Feb 7, 2017 | Issued |
Array
(
[id] => 14793951
[patent_doc_number] => 10399967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Compounds for inflammation and immune-related uses
[patent_app_type] => utility
[patent_app_number] => 15/424097
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34673
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424097
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424097 | Compounds for inflammation and immune-related uses | Feb 2, 2017 | Issued |
Array
(
[id] => 12367047
[patent_doc_number] => 09957217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Conversion of alcohols to carboxylic acids using heterogeneous palladium-based catalysts
[patent_app_type] => utility
[patent_app_number] => 15/420378
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 32
[patent_no_of_words] => 15575
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/420378 | Conversion of alcohols to carboxylic acids using heterogeneous palladium-based catalysts | Jan 30, 2017 | Issued |
Array
(
[id] => 12850825
[patent_doc_number] => 20180175448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => LIQUID ELECTROLYTE FOR BATTERY
[patent_app_type] => utility
[patent_app_number] => 15/421136
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421136 | Liquid electrolyte for battery | Jan 30, 2017 | Issued |
Array
(
[id] => 11627241
[patent_doc_number] => 20170137431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/417785
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 16370
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417785
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417785 | MOLECULAR CONTAINERS AND METHODS OF MAKING AND USING SAME | Jan 26, 2017 | Abandoned |
Array
(
[id] => 14072183
[patent_doc_number] => 20190084979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => WATER-SOLUBLE MYOSIN 2 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL, NEUROPATHIC OR PSYCHIATRIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/073597
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073597 | Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases | Jan 26, 2017 | Issued |
Array
(
[id] => 11618288
[patent_doc_number] => 20170128475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING ORGAN INJURY AND/OR DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/414001
[patent_app_country] => US
[patent_app_date] => 2017-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8325
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414001 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING ORGAN INJURY AND/OR DYSFUNCTION | Jan 23, 2017 | Abandoned |
Array
(
[id] => 12343737
[patent_doc_number] => 09950076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Maytansinoid derivatives, conjugates thereof, and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/414537
[patent_app_country] => US
[patent_app_date] => 2017-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33395
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414537
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414537 | Maytansinoid derivatives, conjugates thereof, and methods of use | Jan 23, 2017 | Issued |
Array
(
[id] => 16696631
[patent_doc_number] => 10947211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Process for the preparation of glycerol carbonate
[patent_app_type] => utility
[patent_app_number] => 16/071745
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 12539
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071745 | Process for the preparation of glycerol carbonate | Jan 19, 2017 | Issued |
Array
(
[id] => 13051365
[patent_doc_number] => 10047063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Method for improving the oxygen-releasing ability of hemoglobin to organs or peripheral tissues in human bodies and a medication thereof
[patent_app_type] => utility
[patent_app_number] => 15/411637
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 29
[patent_no_of_words] => 4651
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411637
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411637 | Method for improving the oxygen-releasing ability of hemoglobin to organs or peripheral tissues in human bodies and a medication thereof | Jan 19, 2017 | Issued |
Array
(
[id] => 14198835
[patent_doc_number] => 10266510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacterial infection, and/or a fungal infection
[patent_app_type] => utility
[patent_app_number] => 15/409175
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12187
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409175 | Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacterial infection, and/or a fungal infection | Jan 17, 2017 | Issued |